1. Home
  2. STAA vs ENOV Comparison

STAA vs ENOV Comparison

Compare STAA & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • ENOV
  • Stock Information
  • Founded
  • STAA 1982
  • ENOV 1995
  • Country
  • STAA United States
  • ENOV United States
  • Employees
  • STAA N/A
  • ENOV N/A
  • Industry
  • STAA Ophthalmic Goods
  • ENOV Fluid Controls
  • Sector
  • STAA Health Care
  • ENOV Industrials
  • Exchange
  • STAA Nasdaq
  • ENOV Nasdaq
  • Market Cap
  • STAA 1.4B
  • ENOV 1.6B
  • IPO Year
  • STAA N/A
  • ENOV 2008
  • Fundamental
  • Price
  • STAA $27.88
  • ENOV $31.86
  • Analyst Decision
  • STAA Hold
  • ENOV Strong Buy
  • Analyst Count
  • STAA 8
  • ENOV 6
  • Target Price
  • STAA $22.50
  • ENOV $51.00
  • AVG Volume (30 Days)
  • STAA 720.4K
  • ENOV 921.7K
  • Earning Date
  • STAA 10-29-2025
  • ENOV 11-05-2025
  • Dividend Yield
  • STAA N/A
  • ENOV N/A
  • EPS Growth
  • STAA N/A
  • ENOV N/A
  • EPS
  • STAA N/A
  • ENOV N/A
  • Revenue
  • STAA $224,449,000.00
  • ENOV $2,189,576,000.00
  • Revenue This Year
  • STAA N/A
  • ENOV $9.13
  • Revenue Next Year
  • STAA $27.59
  • ENOV $6.39
  • P/E Ratio
  • STAA N/A
  • ENOV N/A
  • Revenue Growth
  • STAA N/A
  • ENOV 14.40
  • 52 Week Low
  • STAA $13.50
  • ENOV $25.47
  • 52 Week High
  • STAA $38.60
  • ENOV $49.83
  • Technical
  • Relative Strength Index (RSI)
  • STAA 68.21
  • ENOV 58.81
  • Support Level
  • STAA $27.52
  • ENOV $30.44
  • Resistance Level
  • STAA $28.38
  • ENOV $32.76
  • Average True Range (ATR)
  • STAA 0.45
  • ENOV 1.00
  • MACD
  • STAA -0.30
  • ENOV 0.05
  • Stochastic Oscillator
  • STAA 63.14
  • ENOV 68.31

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: